Back
Travere Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
TVTX
Travere Therapeutics, Inc.
Last Price:
$34.5100
Seasonality Move:
38.05%
7 Day Trial
ALL ACCESS PASS
$
7
Travere Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1349.1% based on the past 19 years of stock performance.
-
Travere Therapeutics, Inc. has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is Travere Therapeutics, Inc. Stock Undervalued?The current Travere Therapeutics, Inc. [TVTX] share price is $34.5000. The Score for TVTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Travere Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1349.1% based on the past 19 years of stock performance.
Travere Therapeutics, Inc. Stock Rating
Buy
68
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. overpriced?
-
Travere Therapeutics, Inc. has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
Travere Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
travere.com
52-Week Data
52-Week High:
37.5000
52-Week Low:
12.9100
Prediction Charts
Market Cap:
3.1B
Price in USD:
34.5000
Volume:
4.6M
Beta:
52.6209
Technical Analysis
SMA50:
32.7379
SMA100:
26.8599
SMA200:
21.9068
52-Wk Change:
98.28%
Stock Predictions
-
Is Travere Therapeutics, Inc. stock public?Yes, Travere Therapeutics, Inc. is a publicly traded company.
-
What is the Travere Therapeutics, Inc. stock quote today?The Travere Therapeutics, Inc. stock price is 34.5000 USD today.
-
How to buy Travere Therapeutics, Inc. stock online?You can buy Travere Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 35.5000 | 33.9900 | 35.6400 | 33.4500 |
| Dec-3 | 34.4100 | 34.8500 | 35.3500 | 34.1000 |
| Dec-4 | 34.4500 | 35.3300 | 35.6350 | 34.4500 |
| Dec-5 | 35.3200 | 35.0000 | 35.5900 | 34.5200 |
| Dec-8 | 35.6050 | 34.2900 | 35.7900 | 34.0000 |
| Dec-9 | 34.2600 | 34.5100 | 35.1800 | 34.2200 |
| Dec-10 | 34.5100 | 34.3800 | 35.1500 | 33.8400 |
| Dec-11 | 34.4200 | 35.0100 | 35.9700 | 33.9000 |
| Dec-12 | 34.7800 | 34.8300 | 35.1300 | 33.9600 |
| Dec-15 | 35.1400 | 34.7600 | 36.2430 | 34.4300 |
| Dec-16 | 34.2300 | 35.8600 | 36.1600 | 34.2300 |
| Dec-17 | 35.7400 | 33.8400 | 36.1700 | 33.4900 |
| Dec-18 | 34.2000 | 34.4950 | 34.5950 | 33.8000 |
| Dec-19 | 34.5100 | 34.5000 | 35.9300 | 34.2500 |
Travere Therapeutics, Inc. Earnings
Travere Therapeutics, Inc. Earnings Report: Per Share Travere Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Travere Therapeutics, Inc. Forecast Revenue Growth
Travere Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.